At a glance
- Originator Merck Sharp & Dohme
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Nausea and vomiting
Most Recent Events
- 26 Feb 1998 New profile
- 26 Feb 1998 Preclinical development for Emesis in England (Unknown route)